Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer
Tingting Yang, Chune Ren, Pengyun Qiao, Xue Han, Li Wang, Shijun Lv, Yonghong Sun, Zhijun Liu, Yu Du, Zhenhai Yu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Mechanisms and Therapy · Peptidase Inhibition and Analysis · Signaling Pathways in Disease
Correction: Oncogene
10.1038/s41388-018-0386-x
In the original version of this article the authors noted that they accidentally used the same image in Fig. 6e: the image for 24 h rHK2 (T473D) was also used for 24 h rHK2 (WT). The amended version of Fig. 6e is provided below. This change does not affect the results or conclusions reported in the manuscript.Fig. 6c–e MCF-7 cells with stable expression of rHK2 (WT, T473A, or T473D) were seeded in a six-well plate. Clone formation, wound healing assay, and cell invasion assays were performed
The figure has now been corrected in both the PDF and HTML versions of the Article.